Worm Breeder's Gazette 2(1): 18

These abstracts should not be cited in bibliographies. Material contained herein should be treated as personal communication and should be cited as such only with the consent of the author.

Levamisole-resistant Mutants with a Wild Type Visible Phenotype

J. Lewis (New York Worm Group)

As described by Brenner, a large fraction of levamisole-resistant 
mutants are worms with a wild type visible phenotype when grown on NG 
plates.  We find that most of these mutants grown in the presence of 
levamisole acquire the peculiar uncoordinated phenotype characteristic 
of the levamisole-resistant uncs.  In our cut worm assay, several of 
these 'wild type' mutant strains showed near wild type susceptibility 
to all drugs tested (including levamisole) when grown in the absence 
of levamisole.  Grown and tested in the presence of levamisole, the 
worms showed extreme resistance to cholinergic agonists but 
sensitivity to the muscle contracting agent ouabain.  The latter 
pharmacological phenotype is characteristic of levamisole-resistant 
uncs and N2 wild type worms treated with cholinergic blocking agents.  
As we mentioned previously, levamisole also acts as an agonist on 
naive worms and is blocked by cholinergic antagonists.  From these 
observations, we infer that levamisole is a cholinergic depolarizing 
blocking agent.  We believe that mutants with a normal visible 
phenotype have less of and/or less functional acetylcholine receptors 
than the wild type-but still workable receptors.  Possibly, levamisole 
depolarizes in binding to the Ac receptor but once bound, has a 
blocking effect.  N2 wild type worms grown on levamisole would always 
have a significant amount of muscle-depolarization due to constant 
dissociation and reassociation of levamisole with the receptor, 
whereas the wild type mutants would have an insignificant absolute 
amount of receptor undergoing this flux-hence only the blocking effect 
is seen after recovery from initial exposure to the drug.
By far the largest fraction and the most resistant 'wild type' 
mutants fall into a gene probably corresponding to tmr-1 described by 
Brenner.  Very rare mutants in this gene are levamisole-resistant uncs 
when homozygous and semi-dominant in the growth test on levamisole!  
Most of the other wild type mutants appear to be leaky alleles of the 
levamisole-resistant unc loci.  A couple of rare birds are sex-linked 
and apparently sexually dimorphic.
Four rather different mutants have been isolated with close to wild 
type visible phenotype and extreme resistance to levamisole even when 
grown in the absence of the drug.  In the cut worm assay they show 
extreme resistance to levamisole and varying susceptibility to other 
cholinergic agonists (unfortunately not a wild type susceptibility to 
acetylcholine).  These might be mutants having the minimal amount of 
functional Ac receptor necessary for a wild type visible phenotype; we 
prefer to think that they are acetylcholine binding protein mutants.  
Three of the four mutants are in unc-29, LG I.